FDA Approves Tirzepatide for Obstructive Sleep Apnea in Patients with Obesity
Zepbound from Eli Lilly is the first and only prescription medicine approved by the FDA for adults with obstructive sleep apnea and obesity.
American Pharmacies: Powering the Profession Through Leadership
Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.
CagriSema Demonstrates Statistically Significant, Superior Weight Loss Vs Placebo
Although the drug fell short of its 25% expected weight loss, results are still promising for people with overweight or obesity.
How Centralized Fulfillment is Making Pharmacy More Efficient
Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.
First Severe Case of Bird Flu Detected in Louisiana
Recent upticks of the bird flu virus in both dairy cattle and humans have also led to a state of emergency in California.
DOJ Lawsuit Alleges CVS Helped Fuel Opioid Epidemic Through Unlawful Opioid Prescriptions
The lawsuit alleges that the company knowingly violated both the Controlled Substances Act and the False Claims Act.
